196 related articles for article (PubMed ID: 11031210)
1. Circulating oxidized low density lipoprotein levels. A biochemical risk marker for coronary heart disease.
Toshima S; Hasegawa A; Kurabayashi M; Itabe H; Takano T; Sugano J; Shimamura K; Kimura J; Michishita I; Suzuki T; Nagai R
Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):2243-7. PubMed ID: 11031210
[TBL] [Abstract][Full Text] [Related]
2. Circulating oxidized low density lipoprotein, autoantibodies against them and homocysteine serum levels in diagnosis and estimation of severity of coronary artery disease.
Faviou E; Vourli G; Nounopoulos C; Zachari A; Dionyssiou-Asteriou A
Free Radic Res; 2005 Apr; 39(4):419-29. PubMed ID: 16028367
[TBL] [Abstract][Full Text] [Related]
3. Simple and practical sandwich-type enzyme immunoassay for human oxidatively modified low density lipoprotein using antioxidized phosphatidylcholine monoclonal antibody and antihuman apolipoprotein-B antibody.
Kohno H; Sueshige N; Oguri K; Izumidate H; Masunari T; Kawamura M; Itabe H; Takano T; Hasegawa A; Nagai R
Clin Biochem; 2000 Jun; 33(4):243-53. PubMed ID: 10936581
[TBL] [Abstract][Full Text] [Related]
4. Circulating oxidized LDL, measured with FOH1a/DLH3 antibody, is associated with metabolic syndrome and the coronary heart disease risk score in healthy Japanese.
Ueba T; Nomura S; Nishikawa T; Kajiwara M; Yamashita K
Atherosclerosis; 2009 Mar; 203(1):243-8. PubMed ID: 18635189
[TBL] [Abstract][Full Text] [Related]
5. Is plasma oxidized low-density lipoprotein, measured with the widely used antibody 4E6, an independent predictor of coronary heart disease among U.S. men and women?
Wu T; Willett WC; Rifai N; Shai I; Manson JE; Rimm EB
J Am Coll Cardiol; 2006 Sep; 48(5):973-9. PubMed ID: 16949489
[TBL] [Abstract][Full Text] [Related]
6. Relationships between serum levels of autoantibodies against oxidized low density lipoproteins, lipid-soluble antioxidants and apolipoprotein B in patients with coronary heart disease.
Bakalova RA; Hadzhimitova V; Ribarov S
Gen Physiol Biophys; 2000 Mar; 19(1):103-13. PubMed ID: 10930142
[TBL] [Abstract][Full Text] [Related]
7. [Atherosclerosis and sensitive determination of oxidized LDL using monoclonal antibody].
Itabe H
Yakugaku Zasshi; 2002 Oct; 122(10):745-53. PubMed ID: 12400156
[TBL] [Abstract][Full Text] [Related]
8. Plasma levels of oxidized low density lipoprotein are associated with stable angina pectoris and modalities of acute coronary syndrome.
Imazu M; Ono K; Tadehara F; Kajiwara K; Yamamoto H; Sumii K; Tasaki N; Oiwa J; Shimohara Y; Gomyo Y; Itabe H
Int Heart J; 2008 Sep; 49(5):515-24. PubMed ID: 18971563
[TBL] [Abstract][Full Text] [Related]
9. Antibodies against human oxidized low-density lipoprotein (LDL) as markers for human plasma modified lipoproteins.
Radulescu L; Stancu C; Antohe F
Med Sci Monit; 2004 Jul; 10(7):BR207-14. PubMed ID: 15232494
[TBL] [Abstract][Full Text] [Related]
10. Temporal increases in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndromes.
Tsimikas S; Bergmark C; Beyer RW; Patel R; Pattison J; Miller E; Juliano J; Witztum JL
J Am Coll Cardiol; 2003 Feb; 41(3):360-70. PubMed ID: 12575961
[TBL] [Abstract][Full Text] [Related]
11. Antibodies to oxidized LDL and LDL-containing immune complexes as risk factors for coronary artery disease in diabetes mellitus.
Lopes-Virella MF; Virella G; Orchard TJ; Koskinen S; Evans RW; Becker DJ; Forrest KY
Clin Immunol; 1999 Feb; 90(2):165-72. PubMed ID: 10080827
[TBL] [Abstract][Full Text] [Related]
12. Inverse relationship between circulating oxidized low density lipoprotein (oxLDL) and anti-oxLDL antibody levels in healthy subjects.
Shoji T; Nishizawa Y; Fukumoto M; Shimamura K; Kimura J; Kanda H; Emoto M; Kawagishi T; Morii H
Atherosclerosis; 2000 Jan; 148(1):171-7. PubMed ID: 10580183
[TBL] [Abstract][Full Text] [Related]
13. Circulating oxidized low-density lipoprotein is an independent predictor for cardiac event in patients with coronary artery disease.
Shimada K; Mokuno H; Matsunaga E; Miyazaki T; Sumiyoshi K; Miyauchi K; Daida H
Atherosclerosis; 2004 Jun; 174(2):343-7. PubMed ID: 15136065
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic implications of circulating oxidized low density lipoprotein levels as a biochemical risk marker of coronary artery disease.
Suzuki T; Kohno H; Hasegawa A; Toshima S; Amaki T; Kurabayashi M; Nagai R; Suzuki T; Amaki T; Nagai R; Hasegawa A; Toshima S; Kurabayashi MH; Shimada K; Nakamura H; Teramoto T; Yamaguchi H; Nishiyama S; Takahashi H; Michishita I; Sugano Z; Konoshi K;
Clin Biochem; 2002 Jul; 35(5):347-53. PubMed ID: 12270763
[TBL] [Abstract][Full Text] [Related]
15. Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease.
Holvoet P; Mertens A; Verhamme P; Bogaerts K; Beyens G; Verhaeghe R; Collen D; Muls E; Van de Werf F
Arterioscler Thromb Vasc Biol; 2001 May; 21(5):844-8. PubMed ID: 11348884
[TBL] [Abstract][Full Text] [Related]
16. Influence of hypercholesterolemia on serum antibodies against oxidized LDL in children and adolescents.
Garoufi A; Marmarinos A; Vraila VM; Dimou S; Pagoni A; Vorre S; Paraskakis I; Gourgiotis D
Pediatr Int; 2018 Mar; 60(3):287-293. PubMed ID: 29297961
[TBL] [Abstract][Full Text] [Related]
17. Oxidized Low-Density Lipoprotein-β2-Glycoprotein I Complex But Not Free Oxidized LDL Is Associated With the Presence and Severity of Coronary Artery Disease.
Bliden KP; Chaudhary R; Lopez LR; Damrongwatanasuk R; Guyer K; Gesheff MG; Franzese CJ; Kaza H; Tantry US; Gurbel PA
Am J Cardiol; 2016 Sep; 118(5):673-8. PubMed ID: 27401271
[TBL] [Abstract][Full Text] [Related]
18. Detection of oxidized low-density lipoproteins in gingival crevicular fluid from dental patients.
Sakiyama Y; Kato R; Inoue S; Suzuki K; Itabe H; Yamamoto M
J Periodontal Res; 2010 Apr; 45(2):216-22. PubMed ID: 19778326
[TBL] [Abstract][Full Text] [Related]
19. Low serum adiponectin is associated with high circulating oxidized low-density lipoprotein in patients with type 2 diabetes mellitus and coronary artery disease.
Lautamäki R; Rönnemaa T; Huupponen R; Lehtimäki T; Iozzo P; Airaksinen KE; Knuuti J; Nuutila P
Metabolism; 2007 Jul; 56(7):881-6. PubMed ID: 17570246
[TBL] [Abstract][Full Text] [Related]
20. Measurement of oxidized lipoprotein (a) in patients with acute coronary syndromes and stable coronary artery disease by 2 ELISAs: using different capture antibody against oxidized lipoprotein (a) or oxidized LDL.
Wang JJ; Han AZ; Meng Y; Gong JB; Zhang CN; Li K; Liu YX
Clin Biochem; 2010 Apr; 43(6):571-5. PubMed ID: 20060390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
